Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Am J Obstet Gynecol
; 225(1): 68.e1-68.e11, 2021 07.
Article
in En
| MEDLINE
| ID: mdl-33549538
Key words
Full text:
1
Main subject:
Ovarian Neoplasms
/
Cost Sharing
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Etiology_studies
/
Health_economic_evaluation
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Am J Obstet Gynecol
Year:
2021
Type:
Article